feed,title,long_url,short_url
Investing,Earnings call: Kura Oncology reports progress with ziftomenib in Q2 2024,https://www.investing.com/news/stock-market-news/earnings-call-kura-oncology-reports-progress-with-ziftomenib-in-q2-2024-93CH-3565347,https://da.gd/TqTo
Investing,Earnings call: Microvast reported a record second quarter revenue of $83.7 million in Q2 2024,https://www.investing.com/news/stock-market-news/earnings-call-microvast-reported-a-record-second-quarter-revenue-of-837-million-in-q2-2024-93CH-3565345,https://da.gd/uAunp
Investing,"Earnings call: AlTi reports Q2 2024 results, focuses on strategic growth",https://www.investing.com/news/stock-market-news/earnings-call-alti-reports-q2-2024-results-focuses-on-strategic-growth-93CH-3565344,https://da.gd/XBY5tX
Investing,Earnings call: Evergy reports growth and reaffirms guidance amid challenges,https://www.investing.com/news/stock-market-news/earnings-call-evergy-reports-growth-and-reaffirms-guidance-amid-challenges-93CH-3565343,https://da.gd/4HQhl
Investing,"Earnings call: Arko Corp faces inflation challenges, maintains guidance",https://www.investing.com/news/stock-market-news/earnings-call-arko-corp-faces-inflation-challenges-maintains-guidance-93CH-3565342,https://da.gd/woXDMu
Investing,Earnings call: CytomX reports progress in cancer treatment pipeline,https://www.investing.com/news/stock-market-news/earnings-call-cytomx-reports-progress-in-cancer-treatment-pipeline-93CH-3565341,https://da.gd/r81FJ
Investing,Earnings call: Pembina Pipeline raises 2024 EBITDA guidance,https://www.investing.com/news/stock-market-news/earnings-call-pembina-pipeline-raises-2024-ebitda-guidance-93CH-3565340,https://da.gd/AC5jj
Investing,"Earnings call: 23andMe reports decreased revenue, narrows losses",https://www.investing.com/news/stock-market-news/earnings-call-23andme-reports-decreased-revenue-narrows-losses-93CH-3565339,https://da.gd/kpeid
